Search for: "Astrazeneca"
Results 1141 - 1160
of 1,246
Sorted by Relevance
|
Sort by Date
11 Jun 2008, 9:47 pm
And lest you think this idea of foreign companies and personnel being pursued for FCPA violations is a purely hypothetical one, I suggest you also check out this post, entitled, "Europe Discovers the FCPA," which lists the following European companies "currently under FCPA investigation by US authorities:" ABB (Switzerland, energy) Alcatel Lucent (France, communications) AstraZeneca (UK-Sweden, pharmaceuticals) BAE Systems (UK, defense) Daimler (Germany, automotive)… [read post]
16 May 2012, 12:22 pm
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1360-66 (11th Cir. 2011) (plaintiff had not pleaded recoverable economic injury); Polk v. [read post]
17 Jul 2024, 12:25 am
SIP-570/2022 and SIP-552/2022), the Court Board for economic disputes of the Russian Supreme Court as the second cassation court considered cassation appeals submitted by the patentee (AstraZeneca AB) and the Rospatent on the above Rulings of the Presidium of the Court for Intellectual Rights to issue its judgements in mid-June of 2024. [read post]
14 Oct 2022, 5:16 am
Outsource or Die The rising costs and complexity of commercializing various drugs have pushed most drug companies—such as AstraZeneca—to restructure their drug-making process from a fully integrated, in-house operation to one leveraging the outsourcing of noncore functions. [read post]
18 Nov 2014, 11:16 am
Today’s post is really three different posts on three unrelated subjects. [read post]
29 Nov 2016, 2:30 am
The AstraZeneca(Commission decision here, General Court decision hereand appeal decision from the CJEU here), Servier and Lundbeck cases and UK GSK case have made the industry sit up and take note, and have arguably been the main factor in the near halving of patent settlements in 2014 compared to previous years. [read post]
10 Jul 2020, 8:59 am
By Rachel Sachs, Jacob S. [read post]
5 Jul 2020, 5:43 am
AstraZeneca, Eli Lilly, Merck Sharp & Dohme, Pfizer and GlaxoSmithKline are working with IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) and the World Health Organisation as part of a global team to speed up the development of safe and effective vaccines and remedies against Covid-19. [read post]
13 Nov 2014, 5:00 am
Courtesy of Mike Imbroscio of Covington (who was on the winning team) today’s post is about a very satisfying Cymbalta win – not only did warning causation fail under the learned intermediary rule, but the warning for the drug was held adequate as a matter of law. [read post]
26 Mar 2021, 5:01 am
As Blinken Visits Europe, China Retaliates Against U.S., EU Xinjiang Sanctions On March 22, the United States, along with the European Union, the United Kingdom and Canada imposed coordinated sanctions on Chinese officials accused of human rights abuses in Xinjiang. [read post]
19 Jul 2013, 10:43 am
AstraZeneca Pharms. [read post]
14 Aug 2013, 1:57 pm
We’ve already provided our readers with our list of the testimony (trial and deposition) of the seemingly ubiquitous plaintiff’s expert Dr. [read post]
12 Mar 2020, 1:48 am
In relation to AstraZeneca, Chris considered that the objection was basically that the company was insufficiently transparent – but he said it was hard to see how it could actually be considered anticompetitive. [read post]
2 Mar 2012, 6:52 am
Astrazeneca (Crestor) Daubert Hearing2007-06-14 Fleet Phospho-Soda Litig. [read post]
9 Aug 2012, 5:00 am
Astrazeneca (Crestor) Daubert Hearing2007-06-14 Fleet Phospho-Soda Litig. [read post]
3 Jan 2012, 10:20 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
15 Aug 2021, 11:51 pm
AstraZeneca The following case illustrates license sought for Saxagliptin® which is used in the treatment of Type-II Diabetes Mellitus On June 29, 2015, Lee Pharma filed an application for compulsory license for patent covering Astra Zeneca’s diabetes management drug Saxagliptin®. [read post]
11 Jan 2022, 11:45 am
In 2015, AstraZeneca and Cephalon paid a total of $54 million to resolve claims that they also improperly reduced AMPs by wrongfully accounting for service fees they paid to wholesalers. [read post]
27 Jul 2014, 5:07 pm
On 22 July 2014, HHJ Moloney QC heard an application in the harassment case of AstraZeneca UK Ltd & anr v Mathai & ors. [read post]
